- Home
- HUT vs DYN Comparison
HUT vs DYN Comparison
Compare HUT & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUT
- DYN
- Stock Information
- Founded
- HUT 2011
- DYN 1984
- Country
- HUT United States
- DYN United States
- Employees
- HUT N/A
- DYN N/A
- Industry
- HUT Finance: Consumer Services
- DYN Medicinal Chemicals and Botanical Products
- Sector
- HUT Finance
- DYN Health Care
- Exchange
- HUT Nasdaq
- DYN Nasdaq
- Market Cap
- HUT 1.7B
- DYN 1.4B
- IPO Year
- HUT N/A
- DYN 2020
- Fundamental
- Price
- HUT $21.87
- DYN $8.76
- Analyst Decision
- HUT Strong Buy
- DYN Strong Buy
- Analyst Count
- HUT 14
- DYN 15
- Target Price
- HUT $26.64
- DYN $43.60
- AVG Volume (30 Days)
- HUT 6.9M
- DYN 3.4M
- Earning Date
- HUT 08-12-2025
- DYN 08-11-2025
- Dividend Yield
- HUT N/A
- DYN N/A
- EPS Growth
- HUT N/A
- DYN N/A
- EPS
- HUT N/A
- DYN N/A
- Revenue
- HUT $132,459,000.00
- DYN N/A
- Revenue This Year
- HUT $74.79
- DYN N/A
- Revenue Next Year
- HUT $116.78
- DYN N/A
- P/E Ratio
- HUT N/A
- DYN N/A
- Revenue Growth
- HUT 0.24
- DYN N/A
- 52 Week Low
- HUT $8.73
- DYN $6.36
- 52 Week High
- HUT $31.95
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- HUT 69.22
- DYN 29.87
- Support Level
- HUT $17.03
- DYN $8.41
- Resistance Level
- HUT $18.88
- DYN $10.74
- Average True Range (ATR)
- HUT 1.25
- DYN 0.77
- MACD
- HUT 0.31
- DYN -0.39
- Stochastic Oscillator
- HUT 90.81
- DYN 5.62
About HUT Hut 8 Corp.
Hut 8 Corp is an energy infrastructure operator and Bitcoin miner with self-mining, hosting, managed services, and traditional data center operations across North America. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.